Sandra Pohlman is co-founder and partner of df-mp. She co-heads the firm’s large and diversified biotechnology and pharmaceuticals practice group. A main part of her practice is oppositions and prosecution before the European Patent Office, where she has consistently obtained favorable results for her clients. Ms. Pohlman is an experienced patent litigator and adviser in the life science patent field. She is qualified to practice before the European Patent Office as a legal practitioner, the Unified Patent Court (UPC) and the German courts. Additionally, she is a registered U.S. Patent Attorney.